| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.018 | 0.9 |